PRX-00023

· Epix Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PRX-00023, covering 2007-11-14 to 2018-12-07. Get the full timeline:

Most recent: Clinical Trial Update: PRX-00023 Therapy in Localization-Related Epilepsy [Phase 2]